Welcome to our dedicated page for Transuite.Org SEC filings (Ticker: TRSO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Transuite.Org Inc. filings document a Nevada public company with disclosures centered on material agreements, controlled subsidiaries, capital structure, and governance changes. Recent 8-K reports describe the company's controlling interest in Goldfinch Group Co., Limited, the related intelligent electric-bicycle charging and management business in China, and cooperation arrangements involving Web3 technology and SolanAI Global Limited.
The filing record also covers amendments to the company's articles of incorporation, including authorized common and preferred stock, preferred-stock authority, indemnification provisions, bylaw authority, and forum-selection provisions. Other disclosures address director and officer appointments and resignations, late annual-report notification, audit-completion timing, and material-event reporting tied to strategic asset integration and corporate repositioning.
Transuite.Org Inc. reported that, effective October 10, 2025, its Board of Directors appointed Mr. Weihua Huang and Mr. Shaoli Jiang as independent directors, and both accepted the roles. The company states there are no appointment-related arrangements with other parties, no family relationships with existing directors or executives, and no related-party transactions requiring disclosure.
Mr. Huang is the founder and CEO of Shenzhen Nth Quantitative Trading Technology Co., Ltd. and has over 20 years of experience in entrepreneurship, corporate management, investment, and digital assets. Mr. Jiang, founder and CEO of GloryEra Holdings, brings over 15 years of experience in financial technology and IT, with prior roles at Yonyou Network Technology, Tencent, Shenzhen Cultural Property Exchange, and Holistic Asset Finance Group.
Transuite.Org Inc. reported a leadership change, with Mengqing Fan resigning as President effective October 9, 2025. The Board appointed Qianglong Zeng as the new President and a Director on the same date.
Zeng is chairman of Puyin Industrial Holding Group in Hong Kong and holds a master’s degree in law from Wuhan University. He has extensive experience in investment banking, venture capital, private equity and large corporate M&A, and is currently focused on AI, crypto and real‑world asset investments. The company states there are no family ties or related‑party transactions requiring disclosure involving Zeng.
Transuite.Org Inc. disclosed that it has entered into and simultaneously closed a Share Exchange Agreement to acquire 100% of Xirangsheng (Shenzhen) Health Technology Co., Ltd. through its subsidiary Crestar Holdings Limited. XRS focuses on AI-powered healthcare technology built around Traditional Chinese Medicine, including AI social agents, a 21‑day health supervision system, and a large library of proprietary TCM health e‑books, with plans for an intelligent e‑commerce platform and multi‑language social media presence.
As initial consideration, Transuite.Org issued 10,000,000 restricted common shares to the seller, Hailiang Li, in an unregistered equity transaction. The agreement includes an earnout-style provision that may result in additional shares being issued based on an independent valuation of XRS and Transuite.Org’s closing share price on September 30, 2025, subject to board approval and securities law compliance.
Transuite.Org Inc. entered into a non-binding Letter of Intent on September 26, 2025 to acquire 51% of Australian licensed digital currency exchange SYD GOLDX PTY LTD through the issuance of Transuite common stock. This potential deal would give Transuite a majority equity interest in SGX if completed.
The Letter of Intent states that both parties will negotiate in good faith toward a definitive agreement, subject to due diligence, final terms, board approvals for both companies, and other customary conditions. Either party may terminate the LOI in writing if due diligence results are unsatisfactory, and the LOI explicitly states it does not create a binding obligation to close the transaction.
Transuite also issued a press release on September 26, 2025 announcing the LOI, which is furnished as an exhibit. Copies of the LOI and the press release are attached as exhibits to this report.
Transuite.Org Inc. signed a non-binding Letter of Intent to acquire 51% of the equity of Fujian Wochong Intelligent Technology Co., Ltd., a company incorporated in China, by issuing TRSO common stock. The final valuation of Wochong will be set after due diligence, and the proposed transaction depends on satisfactory due diligence, board approvals for both companies, no material adverse changes, and required third-party consents.
The LOI includes mutual confidentiality and allows either party to terminate in writing if due diligence results are unsatisfactory. It expressly states that it is not a binding commitment to complete the transaction, which remains subject to negotiation and execution of definitive agreements. Transuite also issued a press release announcing the LOI.
Transuite.Org Inc. signed a non-binding Letter of Intent to acquire 51% of the equity of Fujian Wochong Intelligent Technology Co., Ltd., a company incorporated in China, by issuing TRSO common stock. The final valuation of Wochong will be set after due diligence, and the proposed transaction depends on satisfactory due diligence, board approvals for both companies, no material adverse changes, and required third-party consents.
The LOI includes mutual confidentiality and allows either party to terminate in writing if due diligence results are unsatisfactory. It expressly states that it is not a binding commitment to complete the transaction, which remains subject to negotiation and execution of definitive agreements. Transuite also issued a press release announcing the LOI.